Lineage Cell Therapeutics In shares owned by UBS Group
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Lineage Cell Therapeutics In by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $210k | 140k | 1.50 |
2023-12-31 | $163k | 145k | 1.13 |
2023-09-30 | $63k | 53k | 1.19 |
2023-06-30 | $87k | 61k | 1.42 |
2023-03-31 | $4.9k | 3.3k | 1.50 |
2022-12-31 | $12k | 11k | 1.15 |
2022-09-30 | $0 | 1.3k | 0.00 |
2022-06-30 | $13k | 11k | 1.12 |
2022-03-31 | $1.0k | 894 | 1.12 |
2021-12-31 | $89k | 40k | 2.24 |
2021-09-30 | $485k | 208k | 2.33 |
2021-06-30 | $15k | 4.5k | 3.36 |
2021-03-31 | $17k | 7.3k | 2.33 |
2020-12-31 | $55k | 25k | 2.24 |
2020-09-30 | $1.3k | 1.1k | 1.12 |
2020-06-30 | $1.5k | 1.4k | 1.12 |
2020-03-31 | $59k | 71k | 0.83 |
2019-12-31 | $173k | 156k | 1.11 |
2019-09-30 | $82k | 84k | 0.98 |